MELOXICAM (Page 8 of 8)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 69097-158-07 Rx ONLY

Meloxicam

Tablets, USP

7.5 mg

PHARMACIST : PLEASE DISPENSE

WITH MEDICATION GUIDE

100 Tablets

Cipla

NDC 69097-159-07 Rx ONLY

Meloxicam

Tablets, USP

15 mg

PHARMACIST : PLEASE DISPENSE

WITH MEDICATION GUIDE

100 Tablets

Cipla

MELOXICAM meloxicam tablet

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69097-158 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MELOXICAM (MELOXICAM) MELOXICAM 7.5 mg

Inactive Ingredients Ingredient Name Strength MAGNESIUM STEARATE SILICON DIOXIDE SODIUM CITRATE

Product Characteristics Color YELLOW Score no score Shape ROUND Size 8mm Flavor Imprint Code C;158 Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:69097-158-15 1000 TABLET in 1 BOTTLE None 2 NDC:69097-158-07 100 TABLET in 1 BOTTLE None 3 NDC:69097-158-12 500 TABLET in 1 BOTTLE None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077929 07/19/2006

MELOXICAM meloxicam tablet

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69097-159 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MELOXICAM (MELOXICAM) MELOXICAM 15 mg

Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE MAGNESIUM STEARATE SODIUM STEARATE

Product Characteristics Color YELLOW Score no score Shape ROUND Size 10mm Flavor Imprint Code CIPLA;159 Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:69097-159-12 500 TABLET in 1 BOTTLE None 2 NDC:69097-159-07 100 TABLET in 1 BOTTLE None 3 NDC:69097-159-15 1000 TABLET in 1 BOTTLE None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA077929 07/19/2006

Labeler — Cipla USA Inc. (078719707)

Revised: 12/2022 Cipla USA Inc.